Purple Biotech Ltd (PPBT)
0.5021
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
0.5128
+0.01
(+2.13%)
After-Hours: 20:00
Purple Biotech 1 Year Total Returns (Daily): -72.56% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -72.56% |
May 15, 2024 | -72.38% |
May 14, 2024 | -72.28% |
May 13, 2024 | -71.74% |
May 10, 2024 | -71.31% |
May 09, 2024 | -71.85% |
May 08, 2024 | -71.81% |
May 07, 2024 | -74.37% |
May 06, 2024 | -73.60% |
May 03, 2024 | -72.75% |
May 02, 2024 | -71.82% |
May 01, 2024 | -73.98% |
April 30, 2024 | -74.31% |
April 29, 2024 | -74.75% |
April 26, 2024 | -75.25% |
April 25, 2024 | -73.94% |
April 24, 2024 | -73.02% |
April 23, 2024 | -74.87% |
April 22, 2024 | -76.75% |
April 19, 2024 | -77.80% |
April 18, 2024 | -77.51% |
April 17, 2024 | -78.81% |
April 16, 2024 | -79.08% |
April 15, 2024 | -70.39% |
April 12, 2024 | -68.34% |
Date | Value |
---|---|
April 11, 2024 | -67.29% |
April 10, 2024 | -65.34% |
April 09, 2024 | -61.56% |
April 08, 2024 | -61.56% |
April 05, 2024 | -63.92% |
April 04, 2024 | -60.23% |
April 03, 2024 | -61.50% |
April 02, 2024 | -62.31% |
April 01, 2024 | -61.53% |
March 28, 2024 | -61.93% |
March 27, 2024 | -66.61% |
March 26, 2024 | -67.61% |
March 25, 2024 | -67.43% |
March 22, 2024 | -67.42% |
March 21, 2024 | -67.85% |
March 20, 2024 | -68.58% |
March 19, 2024 | -66.22% |
March 18, 2024 | -66.19% |
March 15, 2024 | -64.98% |
March 14, 2024 | -66.41% |
March 13, 2024 | -64.44% |
March 12, 2024 | -64.44% |
March 11, 2024 | -62.92% |
March 08, 2024 | -63.35% |
March 07, 2024 | -61.52% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.90%
Minimum
Mar 13 2020
114.0%
Maximum
Mar 15 2021
-37.29%
Average
-43.46%
Median
Dec 27 2023
1 Year Total Returns (Daily) Benchmarks
Compugen Ltd | 177.9% |
Pluri Inc | -5.57% |
BioLine Rx Ltd | -52.45% |
Can Fite Biofarma Ltd | 6.03% |
BiomX Inc | 24.57% |